Overview
Mark Robson is an Oncologist in New York, New York. Dr. Robson is rated as a Distinguished provider by MediFind in the treatment of BRCA Positive Breast Cancer. His top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Breast Cancer in Men, Ovarian Cancer, and Salpingo-Oophorectomy.
His clinical research consists of co-authoring 330 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of BRCA Positive Breast Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- INSURANCE PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1275 York Ave, New York, NY 10065
300 E 66th St, New York, NY 10065
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
Icahn School Of Medicine At Mount Sinai
Stephanie Blank is a Gynecologic Oncologist and an Oncologist in New York, New York. Dr. Blank is rated as a Distinguished provider by MediFind in the treatment of BRCA Positive Breast Cancer. Her top areas of expertise are Malignant Mixed Mullerian Tumor, Endometrial Cancer, Li-Fraumeni Syndrome, Bladder Reconstruction, and Hysterectomy.
WPHPA Cancer And Blood Specialists Of New York
Dr. Dan Costin is Director of the White Plains Hospital Center for Cancer Care. He has been practicing medical oncology and hematology in Westchester since 1993. He received his B.S. in biochemistry at the University of California in Los Angeles and his medical degree at the University of California in San Francisco. He completed his internal medicine residency at Beth Israel Hospital in Boston in 1990, his fellowship in medical oncology at the National Cancer Institute in Bethesda in 1991, and his fellowship in hematology at New York University in 1993. He has been an attending physician at White Plains Hospital since 1993 and served as section chief of the department of Hematology-Oncology from 1999 to 2007. Dr. Costin is rated as a Distinguished provider by MediFind in the treatment of BRCA Positive Breast Cancer. His top areas of expertise are Paget Disease of the Breast, Chondrosarcoma, Osteosarcoma, and Angiosarcoma.
Julie Gold is a Hematologist and an Oncologist in Mount Kisco, New York. Dr. Gold is rated as a Distinguished provider by MediFind in the treatment of BRCA Positive Breast Cancer. Her top areas of expertise are Inflammatory Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and HER-2 Positive Breast Cancer.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Breast CancerDr. Robson isElite. Learn about Breast Cancer.
- Triple-Negative Breast Cancer
- Distinguished
- BRCA Positive Breast CancerDr. Robson isDistinguished. Learn about BRCA Positive Breast Cancer.
- Breast Cancer in MenDr. Robson isDistinguished. Learn about Breast Cancer in Men.
- Lynch SyndromeDr. Robson isDistinguished. Learn about Lynch Syndrome.
- Ovarian CancerDr. Robson isDistinguished. Learn about Ovarian Cancer.
- Paget Disease of the BreastDr. Robson isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- AngiosarcomaDr. Robson isAdvanced. Learn about Angiosarcoma.
- Colorectal CancerDr. Robson isAdvanced. Learn about Colorectal Cancer.
- Endometrial CancerDr. Robson isAdvanced. Learn about Endometrial Cancer.
- HER2 Negative Breast CancerDr. Robson isAdvanced. Learn about HER2 Negative Breast Cancer.
- Inflammatory Breast CancerDr. Robson isAdvanced. Learn about Inflammatory Breast Cancer.
- Prostate CancerDr. Robson isAdvanced. Learn about Prostate Cancer.
- Experienced
- Adult Soft Tissue SarcomaDr. Robson isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Brain TumorDr. Robson isExperienced. Learn about Brain Tumor.
- Familial Colorectal CancerDr. Robson isExperienced. Learn about Familial Colorectal Cancer.
- Familial Prostate CancerDr. Robson isExperienced. Learn about Familial Prostate Cancer.
- Gallbladder AdenocarcinomaDr. Robson isExperienced. Learn about Gallbladder Adenocarcinoma.
- HER-2 Positive Breast CancerDr. Robson isExperienced. Learn about HER-2 Positive Breast Cancer.